Digital Healthcare Stakeholders Collaborate on Solutions for Sensor Data Integration

Initiative addresses barriers to effective and efficient use of digital health products at scale

News provided by

Oct 20, 2021, 07:00 ET

BOSTON, Oct. 20, 2021 /PRNewswire/ -- The Digital Medicine Society (DiMe) today announced its next open-science collaboration focused on the integration of sensor generated data into data platforms to power clinical research and patient care. The new initiative will develop resources to improve the effective and efficient use of digital health products in clinical research and patient care, enabling researchers and clinicians to use increasingly ubiquitous sensor data to make better decisions, faster.

"In order to expand the use of digital sensor products and fulfill the promise of digital health measurement to redefine healthcare, stakeholders including clinicians, researchers, patients, regulators, and payers must be able to leverage sensor data that is trustworthy, relevant, and accessible," says Ieuan Clay, Chief Scientific Officer at DiMe. "We have identified this as the biggest limitation to scaling digital health measurement and have gathered a best in class project team with regulators, cloud and analytics platforms, healthcare systems, pharmaceutical, and standards organizations to help us design the solutions."

Catalyzed by the COVID-19 crisis, the use of digital health measurement has been growing rapidly across clinical research and patient care. Recent initiatives by DiMe, such as The Playbook which serves as the foundation for digital measurement and remote monitoring, have supported the safe, effective, and equitable implementation of digital health into practice.

However, despite DiMe's Library of Digital Endpoints observing a 665% spike in the number of unique digital endpoints being used in industry sponsored trials of new medical products over the past two years, we have yet to see a new medical product approved using sensor data. Additionally, while the press reported on a 'monumental shift towards remote patient monitoring', only 11% of telehealth visits during the pandemic used remote patient monitoring.

Digital clinical measures and remote patient monitoring cannot become an integral part of clinical research and clinical care if the technical and business processes that combine sensor data with other relevant information cannot render at scale a unified, single view of the data that is sufficiently trustworthy, relevant, and accessible for high quality decision making.

"If we want to keep our current momentum, our industry will require a set of guidelines that address the considerations involved with integrating these data into platforms that manage study data or help clinicians guide patient care. DiMe is thrilled to lead this new initiative to develop a deep understanding of these gaps and begin to address them, " shared Jennifer Goldsack, Chief Executive Officer at DiMe.

Participating organizations include:

Amazon Web Services (AWS)
Center for Drug Evaluation and Research, US Food and Drug Administration
Center for Devices and Radiological Health, US Food and Drug Administration
Evidation
HumanFirst
IEEE Standards Association
Medable
Moffitt Cancer Center
Oracle
Open mHealth
Savvy Coop
Takeda
Veterans Health Administration

About the Digital Medicine Society: The Digital Medicine Society (DiMe) is the professional society serving the digital medicine community, driving scientific progress and broad acceptance of digital medicine to enhance public health. At DiMe, our commitment to fully integrating experts from all of the disciplines comprising digital medicine is unwavering. From regulators to white-hat hackers, ethicists to engineers, and clinicians to citizen scientists, we are proud to welcome all experts committed to ensuring that digital medicine realizes its full potential to improve human health. Join us!

Media Contact: Jamie Gray, [email protected], 310.699.3163

SOURCE Digital Medicine Society (DiMe)